Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease

被引：0
|
作者：
Axel Facius
Eleonora Marostica
Philip Gardiner
Henrik Watz
Gezim Lahu
机构：
[1] thinkQ2 AG,RIA QCP, IMED Biotech Unit
[2] LAP&P Consultants BV,Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL)
[3] AstraZeneca,undefined
[4] Pulmonary Research Institute at Lung Clinic Grosshansdorf,undefined
来源：
Clinical Pharmacokinetics | 2018年 / 57卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1029 / 1038
页数：9
相关论文
共 50 条
  • [1] Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease
    Facius, Axel
    Marostica, Eleonora
    Gardiner, Philip
    Watz, Henrik
    Lahu, Gezim
    CLINICAL PHARMACOKINETICS, 2018, 57 (08) : 1029 - 1038
  • [2] Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
    Kipourou, Maria
    Begou, Olga
    Manika, Katerina
    Ismailos, Georgios
    Kontou, Paschalina
    Pitsiou, Georgia
    Gika, Helen
    Kioumis, Ioannis
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [3] Efficacy Of Roflumilast In Elderly Patients With Chronic Obstructive Pulmonary Disease
    Hanania, N. A.
    Dransfield, M. T.
    Goehring, U. -M.
    Lakkis, H.
    Rowe, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [4] Effects of Roflumilast on Chronic Bronchitis Symptom in Patients of Chronic Obstructive Pulmonary Disease
    Joo, H.
    Kim, J.
    Kim, K.
    Kyu, Y. Hyoung
    Rhee, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients
    Liu, Dong-yang
    Wang, Zhi-guo
    Gao, Yuan
    Zhang, Hui-min
    Zhang, Yu-xiang
    Wang, Xiao-jun
    Peng, Dan
    MEDICINE, 2018, 97 (07)
  • [6] Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
    Ostrovskyy, Mykola
    Savelikhina, Iryna
    Ostrovska, Kseniia
    Varunkiv, Oleksandr
    Kulynych-Miskiv, Mariana
    Korzh, Galyna
    Shvets, Kostiantyn
    Korzh, Nadiia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [7] Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
    Kim, Kyung Hoon
    Kang, Hye Seon
    Kim, Ju Sang
    Yoon, Hyoung Kyu
    Kim, Sung Kyoung
    Rhee, Chin Kook
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3449 - 3456
  • [8] RISK OF DIARRHEA IN ADULT PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TAKING ROFLUMILAST
    Asfaw, A. A.
    Lee, I
    Lee, T. A.
    Sharp, L. K.
    Wilken, L.
    Joo, M.
    Calip, G. S.
    VALUE IN HEALTH, 2020, 23 : S356 - S356
  • [9] ADHERENCE AND PERSISTENCE TO ROFLUMILAST AMONG ADULT PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Asfaw, A. A.
    Lee, I
    Lee, T. A.
    Sharp, L. K.
    Wilken, L.
    Joo, M.
    Calip, G. S.
    VALUE IN HEALTH, 2020, 23 : S360 - S361
  • [10] Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
    van Noord, JA
    Smeets, JJ
    Clusters, FLJ
    Korducki, L
    Cornelissen, PJG
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (04) : 639 - 644
12345